2results about How to "Improve insomnia" patented technology

The present application relates to the technical field of traditional Chinese medicine. More particularly, it relates to a traditional Chinese medicine composition for tumor-related insomnia, a traditional Chinese medicine preparation thereof and application. The traditional Chinese medicine composition comprises the following raw medicinal materials: Baijiangxi, Xiaakucao, Hehuanpi, Wumei, Shouwuteng, Baiwei and Jinqiaomai. The present application also discloses a traditional Chinese medicine preparation of the above-mentioned traditional Chinese medicine composition and application in preparing a medicine for tumor-related insomnia. The traditional Chinese medicine composition provided by the present application has a scientific and reasonable formula and plays a role in communicating Yin and Yang and detoxifying and relieving depression in view of the core pathogenesis of tumor-related insomnia patients, i.e. 'interchange of Yin and Yang and internal accumulation of depression toxin', and has a significant advantage in improving the severity of insomnia and sleep quality of tumor-related insomnia patients.

The application discloses to belong to the field of biological medicine, and particularly relates to a compound plant exosome composition, a preparation method and application thereof in preparation of a Parkinson's disease treatment medicine. The compound plant exosome composition is a mixed exosome population obtained by co-extraction of six traditional Chinese medicinal materials, namely, radix codonopsis, radix ophiopogonis, fructus schisandrae, semen ziziphi spinosae, radix salviae miltiorrhizae and medlar, breaks through the technical prejudice that only exosomes of single medicinal material are effective, and produces a synergistic effect after compounding and co-extraction. Behavioral experiment results show that the compound plant exosome composition can effectively relieve anxiety, depression, insomnia and other non-motor symptoms of a Parkinson's disease model mouse, and the effect is significantly better than that of a traditional Chinese medicine decoction and a single-exosome physical mixing group. The application provides a new drug selection for treatment of Parkinson's disease, and particularly provides an innovative intervention strategy for Parkinson's disease related non-motor symptoms which have long lacked effective treatment means.